These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32344180)

  • 21. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Small white sign" in Barrett's esophageal cancer under the squamous epithelium.
    Hashimoto R; Hirasawa D; Chonan A; Yamaoka H; Nakahori M
    Gastrointest Endosc; 2017 Jul; 86(1):231-233. PubMed ID: 28012816
    [No Abstract]   [Full Text] [Related]  

  • 23. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma.
    Wang Z; Da Silva TG; Jin K; Han X; Ranganathan P; Zhu X; Sanchez-Mejias A; Bai F; Li B; Fei DL; Weaver K; Carpio RV; Moscowitz AE; Koshenkov VP; Sanchez L; Sparling L; Pei XH; Franceschi D; Ribeiro A; Robbins DJ; Livingstone AS; Capobianco AJ
    Cancer Res; 2014 Nov; 74(21):6364-74. PubMed ID: 25164006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of mutations in Toll-like receptor pathway genes on esophageal carcinogenesis.
    Fels Elliott DR; Perner J; Li X; Symmons MF; Verstak B; Eldridge M; Bower L; O'Donovan M; Gay NJ; ; Fitzgerald RC
    PLoS Genet; 2017 May; 13(5):e1006808. PubMed ID: 28531216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of the impact of Vitamin C supplementation with neoadjuvant chemoradiation on regulators of inflammation and carcinogenesis in esophageal cancer patients.
    Abdel-Latif MMM; Babar M; Kelleher D; Reynolds JV
    J Cancer Res Ther; 2019; 15(1):185-191. PubMed ID: 30880777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LGR5 in Barrett's Esophagus and its Utility in Predicting Patients at Increased Risk of Advanced Neoplasia.
    Neyaz A; Odze RD; Rickelt S; Nieman LT; Bledsoe JR; Mahadevan KK; Arora K; Jeck WR; Taylor MS; Gala M; Patil DT; Yilmaz OH; Rivera MN; Ting DT; Deshpande V
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00272. PubMed ID: 33464729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma.
    Wang Q; Ma C; Kemmner W
    BMC Cancer; 2013 Mar; 13():137. PubMed ID: 23514407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis.
    Xu JH; Wang YC; Geng X; Li YY; Zhang WM
    Pathobiology; 2009; 76(1):23-9. PubMed ID: 19188747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal Adenocarcinomas.
    Blum AE; Venkitachalam S; Guo Y; Kieber-Emmons AM; Ravi L; Chandar AK; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Barnholtz-Sloan JS; Markowitz SD; Willis JE; Shyr Y; Chak A; Varadan V; Guda K
    Cancer Res; 2016 Oct; 76(19):5628-5633. PubMed ID: 27503924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma.
    Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG
    Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esophageal carcinoma originating in the surface epithelium with immunohistochemically proven esophageal gland duct differentiation: A case report.
    Tamura H; Saiki H; Amano T; Yamamoto M; Hayashi S; Ando H; Doi R; Nishida T; Yamamoto K; Adachi S
    World J Gastroenterol; 2017 Jun; 23(21):3928-3933. PubMed ID: 28638233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis.
    Koyama S; Maruyama T; Adachi S
    J Cancer Res Clin Oncol; 1999; 125(1):47-54. PubMed ID: 10037277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival-associated alternative splicing signatures in esophageal carcinoma.
    Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J
    Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma.
    Nancarrow DJ; Clouston AD; Smithers BM; Gotley DC; Drew PA; Watson DI; Tyagi S; Hayward NK; Whiteman DC; ;
    PLoS One; 2011; 6(7):e22513. PubMed ID: 21829465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.
    Han N; Zhang YY; Zhang ZM; Zhang F; Zeng TY; Zhang YB; Zhao WC
    Medicine (Baltimore); 2021 May; 100(20):e25932. PubMed ID: 34011067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing caspase-1 involvement during esophageal disease progression.
    Barber G; Anand A; Katarzyna Oficjalska ; Phelan JJ; Heeran AB; Flis E; Clarke NE; Watson JA; Strangmann J; Flood B; O'Neill H; O'Toole D; MacCarthy F; Ravi N; Reynolds JV; Kay EW; Quante M; O'Sullivan J; Creagh EM
    Cancer Immunol Immunother; 2020 Dec; 69(12):2635-2649. PubMed ID: 32613271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
    Akizue N; Okimoto K; Arai M; Hirotsu Y; Amemiya K; Oura H; Kaneko T; Tokunaga M; Ishikawa K; Ohta Y; Taida T; Saito K; Maruoka D; Matsumura T; Nakagawa T; Nishimura M; Chiba T; Matsushita K; Mochizuki H; Yokosuka O; Omata M; Kato N
    Cancer Med; 2021 Jun; 10(11):3545-3555. PubMed ID: 33934524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of hypoxia-regulated gene expression in loco-regional gastroesophageal cancer.
    Winther M; Alsner J; Tramm T; Holtved E; Baeksgaard L; Nordsmark M
    Acta Oncol; 2016 May; 55(5):652-5. PubMed ID: 26623712
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma.
    Choy B; Bandla S; Xia Y; Tan D; Pennathur A; Luketich JD; Godfrey TE; Peters JH; Sun J; Zhou Z
    BMC Gastroenterol; 2012 Oct; 12():146. PubMed ID: 23078618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.